Clinical trial
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
NCT00362206 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00362206 |
|---|---|
| Title | Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin |
| Official title | A Multicenter, Double-Blind, Randomized, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With 40 mg Pravastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled… |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Fenofibrate/Simvastatin, Pravastatin |
| Enrollment | 423 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Aug 9, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | Greece, Israel, Romania, Russia, South Africa |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: